Details for New Drug Application (NDA): 018702
✉ Email this page to a colleague
NDA 018702 describes ACLOVATE, which is a drug marketed by Fougera Pharms and is included in two NDAs. Additional details are available on the ACLOVATE profile page.
The generic ingredient in ACLOVATE is alclometasone dipropionate. There are three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the alclometasone dipropionate profile page.
The generic ingredient in ACLOVATE is alclometasone dipropionate. There are three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the alclometasone dipropionate profile page.
Summary for 018702
| Tradename: | ACLOVATE |
| Applicant: | Fougera Pharms |
| Ingredient: | alclometasone dipropionate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | OINTMENT;TOPICAL | Strength | 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Dec 14, 1982 | TE: | RLD: | Yes | |||||
Expired US Patents for NDA 018702
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Fougera Pharms | ACLOVATE | alclometasone dipropionate | OINTMENT;TOPICAL | 018702-001 | Dec 14, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription
